Caliber Pharmaceuticals Pvt Ltd - Due diligence report

A 360° intelligence report on Caliber Pharmaceuticals Pvt Ltd: trust score, financial health, credit view, compliance, directors, growth and…

1996-06-18 Assam, Assam Active Unlisted Active Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Caliber Pharmaceuticals Pvt Ltd — 360° Intelligence Report

Generated from MCA filings & public records
80/100
Trust Score
Low Risk

Caliber Pharmaceuticals Pvt Ltd is assessed as Low Risk with a Trust Score of 80/100. Caliber Pharmaceuticals Pvt Ltd is an active private limited indian non-government company incorporated in 1996, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 16 Oct 2026 from the latest processed filings. Caliber Pharmaceuticals Pvt Ltd snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
80/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
55/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 38%).
  • Profitable - internal accruals available.

Charges position: 1 open (50.00 Lakh) · 1 satisfied (52.57 Lakh).

Banking relationships (from registered charges)
LenderChargesAmount
Canara Bank1 48.0 cr
Hdfc Bank Limited1 48.0 cr
Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SAWAR MAL AGARWALA 01234567 Director 01/04/2018 6 yrs Approved
NATWAR LAL AGARWALA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2019 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold the largest single block of equity - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 75 · Distress 75
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Net margin improved to 2.1x.
Operating for 30+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
1 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence82/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment59/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 50.00 Lakh already registered.
  • Compliance record supports lending.
Investor view69/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 8 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
08 Mar 2017
Charge satisfied
Canara Bank
05 Dec 2016
Charge created
Hdfc Bank Limited - 50.00 Lakh
11 Oct 2001
Director appointed
SAWAR MAL AGARWALA (Director)
22 Dec 1999
Charge created
Canara Bank - 52.57 Lakh
18 Jun 1996
Incorporated
Registered with Roc Guwahati
Director appointed
NATWAR LAL AGARWALA (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold the largest single block of equity as per the FY 2019 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Assam Manipur Carriers Pvt Ltd U60231AS1985PTC002456 Kamrup, Assam
Swastika Savings & Services Pvt Ltd U65191AS1974PTC001549 Kamrup, Assam
Kathpal Enterprises Private Limited. U51109AS1997PTC004953 Kamrup, Assam
Kamini Finance And Investment Company Ltd L65929AS1986PLC002518 Kamrup, Assam
Dg Associates Private Limited U15412AS2002PTC006892 Kamrup, Assam
Ispat Sheets Ltd U27107AS1988PLC002877 Kamrup, Assam
Pragjoyti Eye Care And Research Centre Pvt Ltd U85120AS1987PTC002833 Kamrup, Assam
Nezone Agencies Pvt Ltd U51101AS1988PTC002847 Kamrup, Assam
Binod Auto Private Limited U50101AS2007PTC008355 Kamrup, Assam
Triple Ivy Food Services Private Limited U56100AS2024PTC026207 Kamrup, Assam
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Caliber Pharmaceuticals Pvt Ltd before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Caliber Pharmaceuticals Pvt Ltd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 75/100, margin trends, ownership structure and peer set for Caliber Pharmaceuticals Pvt Ltd - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 80/100, distress signals and MSME payment-delay disclosures - know whether Caliber Pharmaceuticals Pvt Ltd pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Caliber Pharmaceuticals Pvt Ltd - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Caliber Pharmaceuticals Pvt Ltd an active company?

Caliber Pharmaceuticals Pvt Ltd has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Caliber Pharmaceuticals Pvt Ltd financially healthy?

Caliber Pharmaceuticals Pvt Ltd has a Financial Health Score of 55/100 (Moderate) based on its filed financial statements.

Should I do business with Caliber Pharmaceuticals Pvt Ltd?

Its overall Trust Score is 80/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Caliber Pharmaceuticals Pvt Ltd?

Promoters hold the largest single block of equity - exact percentages are in the full report. 2 active director(s) are on record.

Does Caliber Pharmaceuticals Pvt Ltd have loans or charges against its assets?

1 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.

Is Caliber Pharmaceuticals Pvt Ltd up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Caliber Pharmaceuticals Pvt Ltd?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.